The world's toughest problems

Solved Through Invention

Inventing For Humanity

Millions of people suffer and die each year in developing countries from causes that humanity has the scientific and technical ability to solve. Global Good is a collaboration between Bill Gates and Intellectual Ventures stemming from the vision of Nathan Myhrvold that addresses these challenges.

Global Good is a collaboration between Bill Gates and Intellectual Ventures

Evolutionin Philanthropy

Global Good combines IV’s unique invention prowess with the expertise of leading humanitarian organizations, forward-looking governments, research institutions and commercial partners that share our vision. Together we invent, develop and deploy commercially-viable technologies that improve life in low-resource countries.

Reverse
Innovation
Approach

Partner
Approach

Reduced Risk

Global Good helps commercial partners identify business opportunities and make informed licensing decisions with minimized upfront risk or financial investment.

We work with governments, NGOs and academic and research organizations from all over the world, leveraging IV’s invention expertise — including the Intellectual Ventures Laboratory — at the earliest stages of an invention’s lifecycle to make commercialization in the developing world feasible by understanding and reducing technology and market risks.

Reduced Risk

Our Work

Global Good’s technology portfolio teams identify and rank critical challenges, define scientific or technical gaps, develop product strategy, prioritize areas for innovation and funding, and lead translational activities for our inventions.

Global Health

Strengthening primary care and health system independence, the management and elimination of diseases and addressing their underlying causes.

Global Development

Improving agricultural value chains with food production systems and modern precision agriculture. Increasing nutritional value and food security. Better access to water and sanitation for low-resource regions

Case Study –
Meet Arktek

Millions of children in low-resource settings live in poverty without access to life-saving vaccines.

Arktek is a super thermos that keeps vaccines at their proper temperature for more than a month — even in scorching desert heat.

Technology Pipeline

Global Health

  • Discovery

  • Development

  • Field

  • Commercialization

Diagnostics & Screening
Low resources culture incubator

Commercialization

High sensitivity malaria rapid diagnostics (P. falciparum)

Field

High sensitivity malaria rapid diagnostics (P. vivax)

Development

High sensitivity TB rapid diagnostic (non-sputum)

Development

Sensitivity-improving lateral flow assay reader

Field

HPV screening oncogenic strains rapid test (NAAT)

Development

Autoscope - Artificially intelligent microscope

Field

Malaria serology

Development

Rapid culture (TB & Sepsis)

Discovery

Predictive Assay for Fever Severity

Discovery

Rapid diagnostic for loiasis (L. Loa filiariasis)

Field

Rapid test for water contamination by E. coli

Development

Automated assessment of precancerous cervical lesions

Field

Other human mycobacteria

Discovery

Biometrics & Monitoring
Cardiopulmonary monitoring

Discovery

Drug quality testing system

Field

Infant biometric system for electronic medical record

Development

Improved mid-upper arm circumference measurement tape

Field

Non Drug Therapeutics
Pediatric oxygen storage system

Development

Pediatric oxygen conservation mask

Development

Postpartum hemorrhaging neural tourniquet

Discovery

Prevention & Vaccine Delivery
Arktek passive vaccine storage system

Commercialization

Arktek deep freeze passive vaccine device

Commercialization

Arktek solar direct drive device

Development

Vector Control
Mosquito aging surveillance assay

Discovery

Indoor biting reduction systems

Discovery

Global Development

  • Discovery

  • Development

  • Field

  • Commercialization

Livestock
Artificial insemination cold shield (AI Shield)

Commercialization

Milk transportation system (Mazzi Can)

Commercialization

CO2 supply for East Coast fever (cattle theileriosis) vaccine logistics

Field

Milk microbial quality test

Development

Livestock feed remediation (Aflatoxin)

Development

Livestock last mile vaccine logistics

Discovery

Livestock diagnostics

Discovery

Pump for lifting water from >7m

Discovery

Siting narrow-bore wells

Discovery

General Agriculture
Grain moisture measurement

Development

Soil and fertilizer nutrient estimation

Development

Nematode soil-borne pathogens

Discovery

Toxin and nutrient detection

Discovery

Fungal detection in soils

Discovery

Special Projects & Spinouts

  • Discovery

  • Development

  • Field

  • Commercialization

Artificial intelligence ultrasound pulmonary assessment

Discovery

MetaFridge solar direct drive vaccine refrigerator

Development

MetaFridge vaccine refrigerator

Field

Extended cold chain outreach systems

Field

Photonic Fence – Flying insect surveillance and killing system

Development

Research
Platforms

Global Good focuses on applied and translational research, leveraging core platforms. Read More

Collaborate
With Us

Global Good’s collaboration model represents an evolution in the philanthropic model, blending measurable commercial value and market-driven impact.

Global Good collaborates with academic and research institutions, NGOs, commercial sector companies, Governments and multilateral organizations to accelerate the translation of impactful technology into wide use.

AUCMA Ashut Worthington Industries MobileODT Nestle SNV

Global Good & Research Leadership

Global Good is supported by a team of dedicated leaders who draw on a diverse mix of experience across business, government and non-profit organizations. We’re united by the belief that invention holds the power to solve some of humanity’s toughest problems.

Global Good works in partnership with the multidisciplinary team of scientists and engineers at the Institute for Disease Modeling and the Intellectual Ventures Laboratory.

Learn More About Global Good

FOLLOW US:

COLLABORATE WITH US

Global Good brings together governments and NGOs, leveraging the full breadth of IV’s invention expertise - including our laboratory, intellectual property and inventor network.

REVERSE INNOVATION APPROACH

Reverse Innovation Approach

Global Good invents affordable, accessible and appropriate technologies that solve the biggest problems in global health and development. First for the people who need it most — the global poor.

Inventions developed to meet the stringent requirements for the most difficult developing world markets are often disruptive enough to transform standards of use and provide benefits everywhere else. We call this reverse innovation.

Through invention and applied and translational science Global Good fills in the key technology gaps in developing countries that improve public health and improve agricultural economies to improve life for millions.

1

of

2

COMMERCIALIZATION PARTNERSHIP APPROACH

Commercialization Partnership Approach

Collaboration partners help us accelerate the development of inventions. And once we prove an invention works, Global Good pursues technology licensing relationships according to Global Access principles with companies that see the long-term market potential of the developing world.

Successful partners view our philanthropic work as a strategic and sustainable enabler of business activity, not only as part of traditional corporate social responsibility. Many have already demonstrated commercial success in these markets with related technology or products.

Following our reverse innovation approach, inventions adopted in low income regions can be re-deployed to other low resource regions in need or even back to higher income markets for profit, creating a market incentive that reinvents philanthropy as a sustainable commercial opportunity.

2

of

2

Maurizio Vecchione

Maurizio Vecchione, Executive Vice President, Global Good & Research

Executive Vice President, Global Good & Research

Maurizio Vecchione is the Executive Vice President of Global Good and Research at Intellectual Ventures (IV). In this role, he oversees IV’s collaboration with Bill Gates to invent and deploy technology specifically focused on improving life in developing countries, as well as the Intellectual Ventures Laboratory and Institute for Disease Modeling. Mr. Vecchione most recently served as CEO of Arrogene, which is commercializing a new nanotechnology platform for cancer therapeutics and diagnostics, and as CEO of telemedicine pioneer CompuMed.

Mr. Vecchione has nearly 30 years of experience in the technology sector. He has contributed to building nine start-ups and helped launch more than 50 commercial products, resulting in more than $1 billion in shareholder value. His work spans the software, internet, wireless and life sciences sectors, primarily in connection with technologies incubated by government and university R&D efforts.

Mr. Vecchione is also involved in a number of non-profit initiatives, including as a co-founder and member of the board of ReefQuest. This global organization focuses on fostering marine environmental stewardship in children through citizen science.

As an inventor himself, Mr. Vecchione is named on multiple U.S. patents and patent applications related to imaging, image processing, nano-bio-polymer and telecommunications technologies. He was twice a finalist for the E&Y Entrepreneur of the Year award, received a DEMO God award from the prestigious DEMO organization and is a member of ACM and IEEE.

David Bell

David Bell, Director – Global Health Technology

Director – Global Health Technology

David Bell is a clinical and public health physician with a background in malariology, tropical health and diagnostics product development. He has previously worked with the World Health Organization in Manila and Geneva, developing strategy and implementation programmes for malaria diagnostics and febrile disease case management, and as head of the Malaria / Acute Febrile Syndrome programme at the Foundation for Innovative New Diagnostics in Geneva, Switzerland. He previously worked as a physician and researcher in Australia, the UK, and the Philippines, and has a PhD in malaria epidemiology and modeling of interventions.

Marie Connett

Marie Connett, Director – Global Development Technology

Director – Global Development Technology

Prior to teaming with Global Good, Marie was the CEO of an NGO active in sustainable agriculture and advised a subsidiary NGO active in climate change mitigation in Africa, India and the Americas. She was also the national R&D Manager for Elders, Australia’s oldest agribusiness, and the Food Security Theme Lead for National ICT Australia with a portfolio including big data and machine learning related to agriculture, water and renewable energy resources.

Marie is an inventor on more than 80 patents and patents pending. She has co-owned and consulted for SME businesses in four countries, and worked over a decade in private industry leading several biochemistry and engineering research groups, including one that pioneered the only scalable techniques for important species in an area of forestry technology. Marie was previously Deputy CEO of Cambia, an NGO in which she led the team that launched the public-good website Patent Lens, developed the prototypes of biological sequence search tools now connecting NIH and USPTO databases, rendition of status and family information, and expansion from a U.S. agriculture database to all patent categories and multiple jurisdictions, for enablement of inventors and development organizations to compile landscapes from public disclosures.

Marie earned a PhD in Plant Sciences (Cornell University), an MBA (USC) and two bachelor’s degrees with honors, in Biology and in Modern Languages (Humboldt State University and Universität Heidelberg), and registrations as a patent agent, professional forester, and IT project manager. She is an adjunct Professor at the University of Western Australia and a Fellow of the School of Engineering, University of Melbourne.

Craig Nakagawa

Craig Nakagawa, Director of Commercialization, Global Good

Director of Commercialization, Global Good

Craig Nakagawa joined Global Good in 2011 as the director of partner development. He leads a team responsible for commercializing Global Good technologies through industry partners and supporting those partners through NGOs, governments, development agencies and others within Global Good’s ecosystem.

Craig has 25 years of investment experience globally in pharmaceuticals, health, telecommunications, and power with a particular focus on African investments in the past 10+ years. Prior to Global Good, Craig’s experience includes equity research and derivative finance at Lehman Brothers in Tokyo, Hong Kong, and New York, corporate development at Teledesic, and social entrepreneurship and early-stage commercial ventures at VillageReach. He has a bachelor’s degree in international studies from the University of Washington, an MBA from the University of Chicago, and is a Chartered Financial Analyst (CFA). Craig is active in social justice and global sustainability issues and is a trustee of the Bainbridge Graduate Institute (BGI), which offered the first MBA in sustainable business.

Guy Ellis

Guy Ellis, General Manager of Operations, Global Good & Research

General Manager of Operations, Global Good & Research

Guy Ellis is the General Manager, Operations for Global Good and Research. In this role, Guy is responsible for operational effectiveness and efficiency for Global Good and the Intellectual Ventures Laboratory. Guy’s responsibilities include strategic and operational planning, metrics and dashboards as well as other broad performance-related activities.

Guy’s experience spans more than 20 years building and maintaining highly effective operations in a variety of business areas within innovative companies. His experience includes eight years in the Invention Investment Fund at Intellectual Ventures where he led groups responsible for patent prosecution, operations, acquisitions, and strategy.

Prior to IV, Guy worked with Cisco where he built the company’s patent prosecution capabilities by growing the portfolio twenty fold over a 4-year period. At Cisco, he conceived of, designed, and implemented groundbreaking IP management software that is still one of the most widely-used tools within the company. Guy began his career working on technology projects in the legal industry. He is a graduate from San Jose State University as well as the University of Washington Foster School of Business Executive Development Program. In addition to this professional experience, Guy is a mentor at UW CoMotion Incubator and a member of the Board of Advisors for Patent Navigation, an early-stage IP software startup.

Robert Hart

Robert Hart, Vice President and General Manager, The Institute for Disease Modeling

Vice President and General Manager, The Institute for Disease Modeling

Robert S. Hart is the Vice President and General Manager of IDM, sponsored by Global Good at Intellectual Ventures. Robert has a Ph.D. in Geophysics as well as a Master of Science degree in Geophysics from the California Institute of Technology (CalTech), and a Bachelor of Science degree in Earth and Planetary Sciences from the Massachusetts Institute of Technology (MIT). He has over thirty years of experience founding and managing high technology-based software firm as an executive officer and venture investor, as well as serving as a board director. He was most recently a founder and the CEO of Veratect Corporation, an open source data mining and analysis firm providing the earliest possible indicators of the emergence of infectious disease worldwide, but with a particular focus on the developing world. Prior to Veratect, highlights of Robert’s career include tenure as the CEO of Corazonx, a cardiac ultrasound software firm; General Partner at SeaPoint Ventures, a venture capital firm focusing on the wireless telecom industry; CEO of Tegic Communications, the developer of the predictive text input software used in most cellular phones; CEO of Optimas Corporation, a digital image analysis firm; and founder and CEO of Sierra Geophysics, a leading provider of applications software to the global oil and gas industry. Robert currently serves on a number of corporate and non-profit boards.

Dan Lieberman

Dan Lieberman, Principal Investigator - Fluid & Respiratory Systems

Principal Investigator - Fluid & Respiratory Systems

Daniel Lieberman joined Intellectual ventures in 2013 and currently leads the Fluid and Respiratory Systems Group developing technologies to bridge resource gaps in global health and development sectors. Daniel is a mechanical engineer by training with over 20 years of experience investigating thermo-fluid systems in a number of areas including cryogenics, respiratory systems, chemically reacting flows, and propulsion devices.

Prior to IV Labs Dan managed a team at an engineering consulting firm engaging in failure analysis and product design, typically in the aftermath of a catastrophe. He has held part-time faculty positions at the University of Southern California and at École des Métiers de l'Aérospatiale de Montréal. He holds a Ph.D. and M.S. in Aeronautics from the California Institute of Technology, a bachelor’s degree in engineering from McGill University, and is a registered Professional Engineer (PE).

Bernhard Weigl

Bernhard Weigl, Principal Investigator - Rapid Diagnostics

Principal Investigator - Rapid Diagnostics

Bernhard H. Weigl is a Principal Investigator at Intellectual Ventures Lab and an Affiliate Professor at the University of Washington, Department of Bioengineering.

Bernhard leads work to develop the next generation of highly sensitive rapid diagnostic assays for diseases of relevance in developing countries, including TB and malaria. His team has recently demonstrated the most sensitive rapid assay for malaria to date. Previously he led the PATH Diagnostics Group where he oversaw global health diagnostics programs funded by a variety of sources such as NIAID and NIBIB, the Grand Challenges program of the Bill and Melinda Gates Foundation, USAID, and the PATH Health Innovation Portfolio.

He also served as Portfolio Leader for Non-communicable Disease Diagnostics and as Director of the National Institutes of Health-funded Center for Point-of-Care Diagnostics for Global Health. His work focuses on diagnostic technology R&D with relevance to Global Health applications including ultra-sensitive strip-based immunoassays, instrument-free molecular assays, and a variety of isothermal amplification assays for low resource settings.

Tola Marts

Tola Marts, Principal Investigator - Electromechanical Devices Group

Principal Investigator - Electromechanical Devices Group

Tola Marts currently manages the Electromechanical Devices Group, overseeing ME and EE support for the Global Development and Global Health Technologies groups at Global Good.

Tola Marts started his career in entrepreneurial engineering software before moving to WA to build rockets for Blue Origin in 2003. In 2012 he joined the Lab, his first project productizing the Arktek passive vaccine storage device. Tola received a B.S. in mechanical engineering from the University of Minnesota.

Tola was elected to the Issaquah City Council in 2009, and served as Council President in 2012. He is currently running for U.S. Congress in Washington's 8th Congressional District.